Skip to main content
Clinical Trials/NCT05056506
NCT05056506
Recruiting
Not Applicable

A Comparison of Limited Endoscopic Sphincterotomy With Endoscopic Papillary Large Balloon Dilation vs. Endoscopic Papillary Large Balloon Dilation for Endoscopic Choledocholithiasis

Jianfeng Yang2 sites in 1 country168 target enrollmentSeptember 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Choledocholithiasis
Sponsor
Jianfeng Yang
Enrollment
168
Locations
2
Primary Endpoint
The incidence of complications
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Endoscopic papillary balloon dilation (EPBD) for choledocholithiasis is known to be comparable to endoscopic sphincterotomy (EST) especially in cases of small stones. With larger stones (> 10 mm), EPBD with conventional balloon, which have a diameter of 6-8 mm, was reported as less effective for extraction of stones, requiring additional mechanical lithotripsy (ML). The present study aims to compare the efficacy and safety of limited EST plus endoscopic papillary balloon dilation (EST-EPBD) with endoscopic papillary large balloon dilation for large choledocholithiasis.

Detailed Description

ERCP is the best option to remove bile duct stones. It can be done by either endoscopic sphincterotomy (EST) or endoscopic papillary balloon dilation (EPBD). Large bile duct stones appear to be more difficult to remove with conventional methods, such as EST and EPBD. Therefore, extraction of large bile duct stones may require mechanical lithotripsy (ML) as an adjunctive procedure. The primary complication of ML is basket and stone impaction, which can lead to complications such as pancreatitis and cholangitis. Some recent studies have reported the efficacy of endoscopic papillary large balloon dilation (EPLBD) alone or combined with limited EST, establishing it as a safe treatment for the removal of large bile duct stones. The investigators conducted the present study to compare the therapeutic outcome and complications between EPLBD alone and limited EST plus EPLBD for the treatment of large bile duct stones.

Registry
clinicaltrials.gov
Start Date
September 1, 2021
End Date
October 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Jianfeng Yang
Responsible Party
Sponsor Investigator
Principal Investigator

Jianfeng Yang

Professor

First People's Hospital of Hangzhou

Eligibility Criteria

Inclusion Criteria

  • large bile duct stones (≥10 mm)

Exclusion Criteria

  • pregnancy
  • refusal of written informed consent
  • Patients with benign or malignant biliary stricture
  • Contraindications to ERCP exist
  • Complicated with acute pancreatitis or acute cholangitis
  • Coagulation dysfunction,thrombocytopenia
  • prior EST or EPBD
  • Patients after gastrointestinal reconstruction

Outcomes

Primary Outcomes

The incidence of complications

Time Frame: within 1 months after the procedure

The incidence of complications

Secondary Outcomes

  • The success rate of 1st session treatment(within 1 months after the procedure)
  • The rate of mechanical lithotripsy(within 1 months after the procedure)
  • Total ercp times(within 1 months after the procedure)
  • Overall successful stone removal rate(within 1 months after the procedure)

Study Sites (2)

Loading locations...

Similar Trials